155 related articles for article (PubMed ID: 31161374)
1. Safety and efficacy of
Xiang Z; Bai M; Li G; Zou B; Zhong Z; Gao F; Wu C; Huang M; Zhang F
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1907-1916. PubMed ID: 31161374
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
[TBL] [Abstract][Full Text] [Related]
3. Short- to mid-term evaluation of CT-guided 125I brachytherapy on intra-hepatic recurrent tumors and/or extra-hepatic metastases after liver transplantation for hepatocellular carcinoma.
Zhang FJ; Li CX; Zhang L; Wu PH; Jiao DC; Duan GF
Cancer Biol Ther; 2009 Apr; 8(7):585-90. PubMed ID: 19276683
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and Clinical Value of CT-guided (125)I Brachytherapy for Bilateral Lung Recurrences from Colorectal Carcinoma.
Wang G; Zhang F; Yang B; Xue J; Peng S; Zhong Z; Zhang T; Lu M; Gao F
Radiology; 2016 Mar; 278(3):897-905. PubMed ID: 26406550
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography-guided iodine-125 brachytherapy for unresectable hepatocellular carcinoma.
Song Z; Ye J; Wang Y; Li Y; Wang W
J Cancer Res Ther; 2019; 15(7):1553-1560. PubMed ID: 31939437
[TBL] [Abstract][Full Text] [Related]
6. Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation.
Chen L; Ying X; Zhang D; Lai L; Wu F; Tu J; Ji J
Cancer Biother Radiopharm; 2021 Dec; 36(10):820-826. PubMed ID: 32551979
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
[TBL] [Abstract][Full Text] [Related]
9. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant iodine-125 brachytherapy for hepatocellular carcinoma after complete hepatectomy: a randomized controlled trial.
Chen K; Xia Y; Wang H; Xiao F; Xiang G; Shen F
PLoS One; 2013; 8(2):e57397. PubMed ID: 23468980
[TBL] [Abstract][Full Text] [Related]
11. Local tumor control of intermediate and advanced stage hepatocellular carcinoma after local ablative treatment with image-guided interstitial high-dose-rate brachytherapy: A subgroup analysis of 286 HCC nodules.
Heinze C; Damm R; Othmer M; Thormann M; Surov A; Hass P; Seidesticker R; Seidensticker M; Ricke J; Powerski M; Pech M; Omari J
Brachytherapy; 2023; 22(2):231-241. PubMed ID: 36697267
[TBL] [Abstract][Full Text] [Related]
12. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
Zhang ZH; Liu QX; Zhang W; Ma JQ; Wang JH; Luo JJ; Liu LX; Yan ZP
World J Gastroenterol; 2017 Nov; 23(43):7735-7745. PubMed ID: 29209114
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of computed tomography-guided
He C; Liu Y; Li Y; Yang L; Li YT; Li SL; Huang XQ
J Cancer Res Ther; 2018; 14(4):754-759. PubMed ID: 29970648
[TBL] [Abstract][Full Text] [Related]
14. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
[TBL] [Abstract][Full Text] [Related]
15. CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique.
Ricke J; Wust P; Stohlmann A; Beck A; Cho CH; Pech M; Wieners G; Spors B; Werk M; Rosner C; Hänninen EL; Felix R
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1496-505. PubMed ID: 15050329
[TBL] [Abstract][Full Text] [Related]
16. Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.
Ricke J; Wust P; Wieners G; Beck A; Cho CH; Seidensticker M; Pech M; Werk M; Rosner C; Hänninen EL; Freund T; Felix R
J Vasc Interv Radiol; 2004 Nov; 15(11):1279-86. PubMed ID: 15525748
[TBL] [Abstract][Full Text] [Related]
17. Incidence and prediction of seed migration to the chest after iodine-125 brachytherapy for hepatocellular carcinoma.
Lin J; Yang W; Jiang N; Zheng Q; Huang J; Huang N; Li A; Jiang H
Brachytherapy; 2017; 16(6):1252-1256. PubMed ID: 28801115
[TBL] [Abstract][Full Text] [Related]
18. The early evaluation of ultrasound-guided iodine-125 interstitial implants for high-risk hepatocellular carcinoma.
Zhang Y; Ding M; Chi JC; Wang T; Shi YP; Zhai B
Brachytherapy; 2019; 18(5):733-739. PubMed ID: 31515049
[TBL] [Abstract][Full Text] [Related]
19. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
[TBL] [Abstract][Full Text] [Related]
20. Image-guided interstitial high-dose-rate brachytherapy in hepatocellular carcinoma.
Mohnike K; Wieners G; Pech M; Seidensticker M; Rühl R; Lopez-Haenninen E; Ricke J
Dig Dis; 2009; 27(2):170-4. PubMed ID: 19546556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]